Drug-Induced Peripheral Neuropathy: Diagnosis and Management
| dc.contributor.author | Merheb, Diala | |
| dc.contributor.author | Dib, Georgette | |
| dc.contributor.author | Zerdan, Maroun Bou | |
| dc.contributor.author | El Nakib, Clara | |
| dc.contributor.author | Alame, Saada M. | |
| dc.contributor.author | Assi, Hazem I. | |
| dc.contributor.department | Internal Medicine | |
| dc.contributor.faculty | Faculty of Medicine (FM) | |
| dc.contributor.institution | American University of Beirut | |
| dc.date.accessioned | 2025-01-24T11:44:18Z | |
| dc.date.available | 2025-01-24T11:44:18Z | |
| dc.date.issued | 2022 | |
| dc.description.abstract | Peripheral neuropathy comes in all shapes and forms and is a disorder which is found in the peripheral nervous system. It can have an acute or chronic onset depending on the multitude of pathophysiologic mechanisms involving different parts of nerve fibers. A systematic approach is highly beneficial when it comes to cost-effective diagnosis. More than 30 causes of peripheral neuropathy exist ranging from systemic and auto-immune diseases, vitamin deficiencies, viral infections, diabetes, etc. One of the major causes of peripheral neuropathy is drug-induced disease, which can be split into peripheral neuropathy caused by chemotherapy or by other medications. This review deals with the latest causes of drug-induced peripheral neuropathy, the population in-volved, the findings on physical examination and various workups needed and how to manage each case. © 2022 Bentham Science Publishers. | |
| dc.identifier.doi | https://doi.org/10.2174/1568009621666210720142542 | |
| dc.identifier.eid | 2-s2.0-85125583483 | |
| dc.identifier.pmid | 34288840 | |
| dc.identifier.uri | http://hdl.handle.net/10938/30430 | |
| dc.language.iso | en | |
| dc.publisher | Bentham Science Publishers | |
| dc.relation.ispartof | Current Cancer Drug Targets | |
| dc.source | Scopus | |
| dc.subject | Brentuximab | |
| dc.subject | Chemotherapy-induced | |
| dc.subject | Disulfiram | |
| dc.subject | Epithelones | |
| dc.subject | Eribulin | |
| dc.subject | Nitrous oxide | |
| dc.subject | Peripheral neuropathy | |
| dc.subject | Platinum drugs | |
| dc.subject | Proteasome inhibitors | |
| dc.subject | Suramin | |
| dc.subject | Taxanes | |
| dc.subject | Vinca alkaloids | |
| dc.subject | Antineoplastic agents | |
| dc.subject | Humans | |
| dc.subject | Peripheral nervous system diseases | |
| dc.subject | Antiinfective agent | |
| dc.subject | Bortezomib | |
| dc.subject | Brentuximab vedotin | |
| dc.subject | Carboplatin | |
| dc.subject | Carfilzomib | |
| dc.subject | Chloroquine | |
| dc.subject | Cisplatin | |
| dc.subject | Colchicine | |
| dc.subject | Dapsone | |
| dc.subject | Docetaxel | |
| dc.subject | Epothilone derivative | |
| dc.subject | Ethambutol | |
| dc.subject | Gold salt | |
| dc.subject | Hydralazine | |
| dc.subject | Isoniazid | |
| dc.subject | Ixabepilone | |
| dc.subject | Leflunomide | |
| dc.subject | Lithium | |
| dc.subject | Metronidazole | |
| dc.subject | Nitrofurantoin | |
| dc.subject | Oxaliplatin | |
| dc.subject | Paclitaxel | |
| dc.subject | Phenytoin | |
| dc.subject | Platinum | |
| dc.subject | Proteasome inhibitor | |
| dc.subject | Quinoline derived antiinfective agent | |
| dc.subject | Quinolone | |
| dc.subject | Sagopilone | |
| dc.subject | Statin (protein) | |
| dc.subject | Taxane derivative | |
| dc.subject | Tryptophan | |
| dc.subject | Tumor necrosis factor receptor superfamily member 8 | |
| dc.subject | Vinblastine | |
| dc.subject | Vinca alkaloid | |
| dc.subject | Vincristine | |
| dc.subject | Antineoplastic agent | |
| dc.subject | Autoimmune disease | |
| dc.subject | Chemotherapy | |
| dc.subject | Cost effectiveness analysis | |
| dc.subject | Diabetes mellitus | |
| dc.subject | Microtubule | |
| dc.subject | Nerve fiber | |
| dc.subject | Nonhuman | |
| dc.subject | Pathophysiology | |
| dc.subject | Peripheral nervous system | |
| dc.subject | Physical examination | |
| dc.subject | Review | |
| dc.subject | Virus infection | |
| dc.subject | Vitamin deficiency | |
| dc.subject | Human | |
| dc.title | Drug-Induced Peripheral Neuropathy: Diagnosis and Management | |
| dc.type | Review |
Files
Original bundle
1 - 1 of 1